Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →
The test has only been performed in the laboratory, and is likely still years away from being available to actual patients.
Thankfully, the story did mention the extremely steep cost of these drugs.
But the story did a good job of reporting on the cost and availability of this procedure.
It’s important to keep in mind that all cancer screening tests carry risks.
It would have been helpful if the story had explored who would pay for this kind of screening, and what we know about depression screening in general: Is it effective?
The release fails to mention that the FDA has issued a warning against the use of vaginal laser surgery for menopausal symptoms.
There was also no information about how or where these research findings were presented, nor was there any input from independent experts.
But it was good to see how the story included the prices of the drugs and mentioned the lack of long-term safety data.
Tips & Resources for Analyzing Health Care Claims